American Association for Cancer Research
Browse
00085472can102429-sup-sfiglegs_1-4.pdf (76.05 kB)

Supplementary Figure Legends 1- 4 from Free Tubulin Modulates Mitochondrial Membrane Potential in Cancer Cells

Download (76.05 kB)
journal contribution
posted on 2023-03-30, 20:24 authored by Eduardo N. Maldonado, Jyoti Patnaik, Matthew R. Mullins, John J. Lemasters
Supplementary Figure Legends 1- 4 from Free Tubulin Modulates Mitochondrial Membrane Potential in Cancer Cells

History

ARTICLE ABSTRACT

Formation of the mitochondrial membrane potential (ΔΨ) depends on flux of respiratory substrates, ATP, ADP, and Pi through voltage-dependent anion channels (VDAC). As tubulin promotes single-channel closure of VDAC, we hypothesized that tubulin is a dynamic regulator of ΔΨ, which in cultured cancer cells was assessed by confocal microscopy of the potential-indicating fluorophore tetramethylrhodamine methylester (TMRM). Microtubule destabilizers, rotenone, colchicine, and nocodazole, and the microtubule stabilizer paclitaxel increased and decreased cellular free tubulin, respectively, and in parallel decreased and increased ΔΨ. Protein kinase A (PKA) activation by cAMP analogues and glycogen synthase kinase 3β (GSK-3β) inhibition decreased ΔΨ, whereas PKA inhibition hyperpolarized, consistent with reports that PKA and GSK-3β decrease and increase VDAC conductance, respectively. Plasma membrane potential assessed by DiBAC4(3) was not altered by any of the treatments. We propose that inhibition of VDAC by free tubulin limits mitochondrial metabolism in cancer cells. Cancer Res; 70(24); 10192–201. ©2010 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC